Hjem › Spiserørkreft › California

Kliniske studier for Spiserørkreft i California

41 studier for Spiserørkreft søker deltakere på steder i California.

Byer i California

Offisiell studietekst (engelsk)

The Vanguard Study: Testing a New Way to Screen for Cancer

Kaiser Permanente-Division of Research, Pleasanton

RekruttererFrivillige helsepersonell ønskes velkommen

Alder 45 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06995898

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06465069

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

UCLA Hematology/Oncology - Santa Monica ( Site 4905), Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05319730

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

City of Hope - Duarte Cancer Center, Duarte

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06760819

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
Mercy Cancer Center - Carmichael, Carmichael
Mercy San Juan Medical Center, Carmichael
og 8 flere

RekruttererFrivillige helsepersonell ønskes velkommen

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07283939

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
og 10 flere

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
og 20 flere

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen

Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

City of Hope National Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine
Ronald Reagan UCLA Medical Center, Los Angeles
og 3 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07090499

DESTINY-PANTUMOUR04

Research Site, San Diego

RekruttererObservasjonsstudie

Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06047379

Pan-tumor MRD Study

Los Angeles Cancer Network (LACN), Glendale
Ventura County Hematology Oncology Specialists, Oxnard
Medical Oncology Associates of San Diego (MOASD), San Diego
og 2 flere

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06605404

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian, Newport Beach
Stanford University Medical Center, Stanford

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

UC IRVINE Health, Orange
UC Davis Comprehensive Cancer Center, Sacramento
Stanford Cancer Institute, Stanford

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Beverly Hills Cancer Center, Beverly Hills
City of Hope Cancer Center, Duarte
University of California Irvine Medical Center, Orange
og 1 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05983432

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Helios CR Inc./RadNet, Cerritos
City of Hope National Cancer Center, Duarte
Hoag Memorial Hospital, Irvine
og 2 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07217704

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

RekruttererObservasjonsstudie

Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

City of Hope, Duarte
START - Los Angeles, Los Angeles
Cedars Sinai, Los Angeles
og 1 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Duarte
Research Site, Fountain Valley
Research Site, Fullerton
og 5 flere

RekruttererFase 3

Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07431281

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

UCLA Hematology/Oncology - Santa Monica ( Site 8905), Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06445972

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

UCLA Hematology/Oncology - Santa Monica ( Site 6905), Los Angeles

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06469944

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07795749

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

UCLA, Santa Monica

RekruttererFase 2

Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07070466

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

UC San Diego Moores Cancer Center, San Diego

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07227168

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

University of California, San Francisco, San Francisco
John Muir Medical Center-Walnut Creek, Walnut Creek

Rekrutterer

Alder 18 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT04221893

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

UCSD, La Jolla
Sharp Healthcare, San Diego

RekruttererFase 1/2

Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT03526835

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Providence Medical Foundation, Anaheim
Providence Medical Foundation, Fullerton
Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
og 7 flere

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

City of Hope National Medical Center /ID# 276272, Duarte
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589, Irvine
USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles

RekruttererFase 1

Alder 18 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT05005403